Single dose primaquine for clearance of Plasmodium falciparum gametocytes in children with uncomplicated malaria in Uganda: a randomised, controlled, double-blind, dose-ranging trial.

Single dose primaquine for clearance of Plasmodium falciparum gametocytes in children with uncomplicated malaria in Uganda: a randomised, controlled, double-blind, dose-ranging trial.

Show other versions (1)

BACKGROUND: Primaquine is the only available drug that clears mature Plasmodium falciparum gametocytes in infected human hosts, thereby preventing transmission of malaria to mosquitoes. However, concerns about dose-dependent haemolysis in people with glucose-6-phosphate dehydrogenase (G6PD) deficien...

Full description

Bibliographic Details
Main Authors:	Eziefula, A, Bousema, T, Yeung, S, Kamya, M, Owaraganise, A, Gabagaya, G, Bradley, J, Grignard, L, Lanke, K, Wanzira, H, Mpimbaza, A, Nsobya, S, White, N, Webb, E, Staedke, S, Drakeley, C
Format:	Journal article
Language:	English
Published:	Elsevier 2014

Similar Items

Single dose primaquine for clearance of Plasmodium falciparum gametocytes in children with uncomplicated malaria in Uganda: A randomised, controlled, double-blind, dose-ranging trial
by: Eziefula, A, et al.
Published: (2014)

Single dose primaquine for clearance of Plasmodium falaparum gametocytes in children with uncomplicated malaria in Uganda: a randomised, controlled, double-blind, dose-ranging trial
by: Eziefula, A, et al.
Published: (2014)

Study protocol for a randomised controlled double-blinded trial of the dose-dependent efficacy and safety of primaquine for clearance of gametocytes in children with uncomplicated falciparum malaria in Uganda
by: Eziefula, A, et al.
Published: (2013)

Efficacy of single dose primaquine with artemisinin combination therapy on P. falciparum gametocytes and transmission: A WWARN individual patient meta-analysis
by: Stepniewska, K, et al.
Published: (2020)

Editorial commentary: single-dose primaquine as gametocytocidal treatment in patients with uncomplicated falciparum malaria.
by: Dondorp, A
Published: (2013)

Sustained efficacy of artesunate-sulfadoxine-pyrimethamine against Plasmodium falciparum in Yemen and a renewed call for an adjunct single dose primaquine to clear gametocytes
by: Atroosh, W.M., et al.
Published: (2016)

Risk factors for gametocyte carriage in uncomplicated falciparum malaria.
by: Price, R, et al.
Published: (1999)

Antibody responses to crude gametocyte extract predict plasmodium falciparum gametocyte carriage in Kenya
by: Omondi, BR, et al.
Published: (2020)

An optimised age-based dosing regimen for single low-dose primaquine for blocking malaria transmission in Cambodia
by: Leang, R, et al.
Published: (2016)

Effect of primaquine dose on the risk of recurrence in patients with uncomplicated Plasmodium vivax: a systematic review and individual patient data meta-analysis
by: Commons, RJ, et al.
Published: (2023)

Factors affecting haemoglobin dynamics in African children with acute uncomplicated Plasmodium falciparum malaria treated with single low-dose primaquine or placebo
by: Onyamboko, MA, et al.
Published: (2023)

Primaquine dose and the risk of haemolysis in patients with uncomplicated Plasmodium vivax malaria: a systematic review and individual patient data meta-analysis
by: Rajasekhar, M, et al.
Published: (2023)

Effect of high-dose or split-dose artesunate on parasite clearance in artemisinin-resistant falciparum malaria.
by: Das, D, et al.
Published: (2013)

Erratum to: An optimised age-based dosing regimen for single low-dose primaquine for blocking malaria transmission in Cambodia
by: Leang, R, et al.
Published: (2016)

Higher-dose primaquine to prevent relapse of Plasmodium vivax malaria
by: Watson, JA, et al.
Published: (2022)

Primaquine to reduce transmission of Plasmodium falciparum malaria in Mali: a single-blind, dose-ranging, adaptive randomised phase 2 trial
by: Dicko, A, et al.
Published: (2016)

Mechanisms of lymphoma clearance induced by high-dose alkylating agents
by: Lossos, Chen, et al.
Published: (2021)

High-dose primaquine regimens against relapse of Plasmodium vivax malaria.
by: Krudsood, S, et al.
Published: (2008)

Safety of single-dose primaquine as a Plasmodium falciparum gametocytocide: a systematic review and meta-analysis of individual patient data
by: Stepniewska, K, et al.
Published: (2022)

Pharmacokinetics of single low dose primaquine in Ugandan and Congolese children with falciparum malaria
by: Mukaka, M, et al.
Published: (2023)

Single dose artemisinin-mefloquine treatment for acute uncomplicated falciparum malaria.
by: Tran, T, et al.
Published: (1994)

A randomised controlled trial to compare the efficacy, safety, and tolerability of low dose, short course primaquine in adults with uncomplicated P. vivax malaria in two hospitals in India
by: Ahmad, SS, et al.
Published: (2024)

Development of weight and age-based dosing of daily primaquine for radical cure of vivax malaria
by: Taylor, WR, et al.
Published: (2021)

Safety of age-dosed, single low-dose primaquine in children with glucose-6-phosphate dehydrogenase deficiency who are infected with Plasmodium falciparum in Uganda and the Democratic Republic of the Congo: a randomised, double-blind, placebo-controlled, non-inferiority trial
by: Taylor, WR, et al.
Published: (2022)

Clinical trial of oral artesunate with or without high-dose primaquine for the treatment of vivax malaria in Thailand.
by: Silachamroon, U, et al.
Published: (2003)

The tolerability of single low dose primaquine in glucose-6-phosphate deficient and normal falciparum-infected Cambodians
by: Dysoley, L, et al.
Published: (2019)

The effect of dosing strategies on the therapeutic efficacy of artesunate-amodiaquine for uncomplicated malaria: a meta-analysis of individual patient data
by: Adjuik, M, et al.
Published: (2015)

Anti-gametocyte antigen humoral immunity and gametocytemia during treatment of uncomplicated falciparum malaria: a multi-national study
by: O'Flaherty, K, et al.
Published: (2022)

Gametocyte carriage in uncomplicated Plasmodium falciparum malaria following treatment with artemisinin combination therapy: A systematic review and meta-analysis of individual patient data
by: Abdulla, S, et al.
Published: (2016)

Gametocyte carriage in uncomplicated plasmodium falciparum malaria following treatment with artemisinin combination therapy: a systematic review and meta-analysis of individual patient data
by: Abdulla, S, et al.
Published: (2016)

Plasmodium falciparum gametocyte dynamics in areas of different malaria endemicity.
by: Stepniewska, K, et al.
Published: (2008)

Primaquine in glucose-6-phosphate dehydrogenase deficiency: an adaptive pharmacometric assessment of ascending dose regimens in healthy volunteers
by: Pukrittayakamee, S, et al.
Published: (2024)

The age-specific incidence of hospitalized paediatric malaria in Uganda
by: Mpimbaza, A, et al.
Published: (2020)

Randomized, controlled dose-optimization studies of dihydroartemisinin-piperaquine for the treatment of uncomplicated multidrug-resistant falciparum malaria in Thailand.
by: Ashley, E, et al.
Published: (2004)

There is no safe dose of prions.
by: Fryer, H, et al.
Published: (2011)

Population pharmacokinetics of quinine in pregnant women with uncomplicated Plasmodium falciparum malaria in Uganda.
by: Kloprogge, F, et al.
Published: (2014)

Effectiveness of five artemisinin combination regimens with or without primaquine in uncomplicated falciparum malaria: an open-label randomised trial.
by: Smithuis, F, et al.
Published: (2010)

Changing malaria fever test positivity among paediatric admissions to Tororo district hospital, Uganda 2012-2019
by: Mpimbaza, A, et al.
Published: (2020)

Up by dose
by: Aronson, J
Published: (1997)

Chloroquine versus hihydroartemisinin-piperaquine with standard high-dose Primaquine given either for 7 days or 14 days in Plasmodium vivax malaria
by: Chu, C, et al.
Published: (2018)